Skip to main content

Bacitracin / polymyxin b ophthalmic Pregnancy and Breastfeeding Warnings

Brand names: AK-Poly-Bac, Polycin, Polycin-B, Polysporin Ophthalmic, Polytracin Ophthalmic

Medically reviewed by Drugs.com. Last updated on Aug 3, 2023.

Bacitracin / polymyxin b ophthalmic Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Bacitracin / polymyxin b ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Both components are poorly absorbed after topical application; both are considered low risk to nursing infants.

See references

Does Bacitracin/polymyxin b ophthalmic interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. (2022) "Product Information. Polysporin (bacitracin-polymyxin B topical)." Apothecon Inc

References for breastfeeding information

  1. (2022) "Product Information. Polysporin (bacitracin-polymyxin B topical)." Apothecon Inc
  2. United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer